The CD44 Protein Family: Roles in Embryogenesis and Tumor Progression

References

• Murakami S, Miyake K, June C H, Kincade P W, Hodes R J. IL-5 induces a Pgp-1 (CD44) bright B cell subpopulation that is highly enriched in proliferative and Ig secretory activity and binds to hyaluronate. J. Immunol 1990; 145: 3618–3627
   PubMed Web of Science ®Google Scholar
• Murakami S, Miyake K, Abe R, Kincade P W, Hodes R J. Characterization of autoantibody-secreting B cells in mice undergoing stimulatory (chronic) graft-versus-host reactions. Identification of a CD44hi population that binds specifically to hyaluronate. J Immunol 1991; 146: 1422–1427
   PubMed Web of Science ®Google Scholar
• Lesley J, Schulte R, Hyman R. Binding of hyaluronic acid to lumphoid cell lines is inhibited by monoclonal antibodies against Pgp-1. Exp Cell Res 1990; 187: 224–233
   PubMed Web of Science ®Google Scholar
• Lesley J, Howes N, Perschl A, Hyman R. Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response. J Exp Med 1994; 180: 383–387
   PubMed Web of Science ®Google Scholar
• Sleeman J, Rudy W, Hofmann M, Moll J, Herrlich P, Ponta H. Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity. J Cell Biol 1996; 135: 1139–1150
   PubMed Web of Science ®Google Scholar
• Naor D, Sionov R V, Ish-Shalom D. CD44: Structure, function and association with the malignant process. Adv Cancer Res 1997; 71: 241–319
   PubMed Web of Science ®Google Scholar
• Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haußmann I, Matzku S, Wenzel A, Ponta H, Herrlich P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65: 13–24
   PubMed Web of Science ®Google Scholar
• Arch R, Wirth K, Hofmann M, Ponta H, Matzku S, Herrlich Zöller P. Participation in normal immune responses of a splice variant of CD44 that encodes a metastatis-inducing domain. Science 1992; 257: 682–685
   PubMed Web of Science ®Google Scholar
• Weiß C, Kolluri Kumar, Keifer E, Göttlicher M. Complementation of Ah receptor deficiency in hepatoma cells: Negative feedback regulation and cell cycle control by the Ah receptor. Exp Cell Res 1996; 226: 154–163
   PubMed Web of Science ®Google Scholar
• DeGrendele C H, Estess P, Picker L J, Siegelman M H. CD44 and its ligand hyaluronate mediate rolling under physiologic flow: A novel lymphocyte-endothelial cell primary adhesion pathway. J Exp Med 1996; 1119–1130: 183
   Google Scholar
• DeGrendele C H, Estess P, Siegelman M H. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 1997; 278: 672–675
   PubMed Web of Science ®Google Scholar
• DeGrendele C H, Kosfiszer M, Estess P, Siegelman M H. CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation. J Immunol 1997; 159: 2549–2553
   PubMed Web of Science ®Google Scholar
• Mohamadzaheh M H, DeGrendele H, Arizpe H, Estess P, Siegelman M. Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44-HA-dependent primary adhesion. J Clin Invest 1998; 101: 97–108
   Google Scholar
• Liao H X, Levesque M C, Patton K, Bergamo B, Jones D, Moody M A, Telen M J, Haynes B F. Regulation of human CD44H and CD44E isoform binding to hyaluonan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies. J Immunol 1993; 151: 6490–6499
   PubMed Web of Science ®Google Scholar
• He Q J, Lesley J, Hyman R, Ishihara K, Kincade P W. Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluonate recognition. J Cell Biol 1992; 119: 1711–1719
   PubMed Web of Science ®Google Scholar
• Stamenkovic I, Aruffo A, Amiot M, Seed B. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 1991; 10: 343–348
   PubMed Web of Science ®Google Scholar
• Sy M-S, Guo Y-J, Stamenkovic I. Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein. J Exp Med 1992; 176: 623–627
   PubMed Web of Science ®Google Scholar
• Bartolazzi R, Peach R, Aruffo A, Stamenjovic I. Interaction between CD44 and hyaluonate is directly implicated in the regulation of tumor development. J Exp Med 1994; 180: 53–66
   PubMed Web of Science ®Google Scholar
• Yu Q, Toole B P, Stamenjovic I. Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function. J Exp Med 1997; 186: 1985–1996
   PubMedGoogle Scholar
• Ayroldi E, Cannarile L, Miglorati G, Bartoli A, Nicoletti I, Riccardi C. CD44 (Pgp-1) inhibits CD3 and dexamethasone-induced apoptosis. Blood 1995; 86
   Google Scholar
• Rudy W, Hofmann M, Schwartz-Albiez R, Zöller M, Heider K-H, Ponta H, Herrlich P. The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res 1993; 53: 1262–1268
   PubMed Web of Science ®Google Scholar
• Sleeman J, Kondo K, Moll J, Ponta H, Herrlich P. Variant exons v6 and v7 together expand the repertoire of glycosaminoglycans bound by CD44. J Biol Chem 1997; 272: 31837–31844
   PubMed Web of Science ®Google Scholar
• Sleeman J P, Arming S, Moll J F, Hekele A, Rudy W, Sherman L S, Kreil G, Ponta H, Herrlich P. Hyaluronate-independent metastatic behavior of CD44 variant-expression pancreatic carcinoma cells. Cancer Res 1996; 56: 3134–3141
   PubMed Web of Science ®Google Scholar
• Reber S, Matzku S, Günthert U, Ponta H, Herrlich P, Zöler M. Retardation of metastatic tumor growth after immunization with metastatis-specific monoclonal antibodies. Int J Cancer 1990; 46: 919–927
   PubMed Web of Science ®Google Scholar
• Seiter S, Arch R, Komitowski D, Hofmann M, Ponta H, Herrlich P, Matzku S, Zöller M. Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 1993; 177: 443–455
   PubMed Web of Science ®Google Scholar
• Heider K H, Hofmann M, Horst E, van den Berg F, Ponta H, Herrlich P, Pals S T. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 1993; 120: 227–233
   PubMed Web of Science ®Google Scholar
• Moll J, Schmidt A, van der Putten H, Plug R, Ponta H, Herrlich P, Zöller M. Accelerated immune response in transigenic mice expressing rat CD44v4-v7 on T cells. J Immunol 1996; 156: 2085–2094
   PubMed Web of Science ®Google Scholar
• Lamb R F, Hennigan R F, Turnbull K, Katsanakis K D, MacKenzhie E D, Birnie G D, Ozanne B W. AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44. Mol Cell Biol 1997; 17: 963–976
   PubMed Web of Science ®Google Scholar
• Hudson D L, Sleeman J, Watt F M. CD44 is the major peanut lectin-binding glycoprotein of human epidermal keratinocytes and plays a role in intercellular adhesion. J Cell Sci 1995; 108: 1959–1970, (Pt 5)
   PubMed Web of Science ®Google Scholar
• Kaya G, Rodriguez I, Jorcano J L, Vassalli P, Stamenhovic I. Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation. Genes Dev 1997; 11: 996–1007
   PubMed Web of Science ®Google Scholar
• Terpe H-J, Stark H, Prehm P, Günthert U. CD44 variant isoforms are preferentially expressed in basal epithelia of non-malignant human fetal and adult tissues. Histochemistry 1994; 101: 78–79
   Google Scholar
• Yu Q, Grammatikakis N, Toole B P. Expression of multiple CD44 isoforms in the apical ectodermal ridge of the embryonic mouse limb. Dev Dyn 1996; 207: 204–214
   Google Scholar
• Yu Q, Toole B P. Common pattern of CD44 isoforms is expressed in morphogenetically active epithelia. Dev Dyn 1997; 208: 1–10
   PubMed Web of Science ®Google Scholar
• Wainright D, Sherman L, Sleeman J, Ponta H, Herrlich P. A splice variant of CD44 expressed in the rat apical ectodermal ridge contributes to limb outgrowth. Ann NY Acad Sci 1996; 785: 345–349
   Google Scholar
• Sherman L, Waintwright D, Ponta H, Herrlich P. A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchym and is required for limb outgrowth. Genes Dev 1998; 12: 1058–1071
   PubMed Web of Science ®Google Scholar
• Zwilling E. Ectoderm-mesoderm relationship in the development of the chick embryo limb bud. J Exp Zool 1955; 128: 423–442
   Google Scholar
• Rubin L, Saunders J W, Jr. Ectodermal-mesodermal interactions in the growth of limb buds in the chick embryo: constancy and temporal limits of the ectodermal induction. Dev Biol 1972; 28: 94–112
   Google Scholar
• Summerbell D, Wolpert L. Precision of development in chick limb morphogenesis. Nature 1973; 244: 228–30
   Google Scholar
• Niswander L, Tickle C, Vogel A, Booth I, Martin G R. FGF-4 replaces the apical ectodermal ridge and directs outgowth and patterning of the limb. Cell 1993; 75: 579–587
   PubMed Web of Science ®Google Scholar
• Niswander L, Martin G R. FGF-4 and BMP-2 have opposite effects on limb outgowth. Nature 1993; 361: 68–76
   PubMed Web of Science ®Google Scholar
• Fallon J, López A, Ros M, Savage M, Olwin B, Simandl B. FGF-2, apical ectodermal ridge growth signal for chick limb development. Science 1994; 264: 104–107
   PubMed Web of Science ®Google Scholar
• Cohn M J, Izpisua-Belmonte J C, Abund H, Heath J K, Tickle C. Fibroblast growth factors induce additional limb development from the flank of chick embryos. Cell 1995; 80: 739–746
   PubMed Web of Science ®Google Scholar
• Mahmood R, Bresnick J, Hornbruch A, Mahony C, Morton N, Colquhoun K, Martin P, Lumsden A, Dickson C, Mason I. A role for FGF-8 in the initiation and maintenance of vertebrate limb bud outgrowth. Curr Bio 1995; 5: 797–806
   PubMed Web of Science ®Google Scholar
• Crossley P H, Minowada G, MacArthur C A, Martin G R. Role for FGF8 in the induction, initiation, and maintenance of chick limb development. Cell 1996; 84: 127–136
   PubMed Web of Science ®Google Scholar
• Vogel A, Rodriguez C, Izpisúa-Belmonte J-C. Involvement of FGF-8 in initiation, outgrowth and patterning of the vertebrae limb. Development 1996; 122: 1737–1750
   PubMed Web of Science ®Google Scholar
• Ohuchi H, Nakagawa T, Yamamoto A, Araga A, Ohata T, Ishimaru Y, Yoshioka H, Kuwana T, Nohno T, Yamasaki M, Itoh N, Noji S. The mesenchymal factor, FGF10, initiates and maintains the outgrowth of the chick limb bud through interaction with FGF-8, an apical ectodermal factor. Development 1997; 124: 2235–2244
   PubMedGoogle Scholar
• Savage M P, Hart C E, Riley B, Sasse J, Olwin B B, Fallon J R. Distribution of FGF-2 suggests it has a role in chick limb bud growth. Dev Dyn 1993; 198: 159–170
   PubMedGoogle Scholar
• Suzuki H R, Sakamoto H, Yoshida T, Sugimora T, Terada M, Solursh M. Localization of Hst-1 transcripts to the apical ectodermal ridge in the mouse embryo. Dev Biol 1992; 150: 219–222
   Google Scholar
• Heikinheimo M, Lawshé A, Shackleford G M, Wilson D B, MacArthur C A. Fgf-8 expression in the post-gastrulation mouse suggests roles in the development of the face, limbs and central nervous system. Mech Dev 1994; 48: 129–138
   PubMed Web of Science ®Google Scholar
• Yayon A, Klagsbrun M, Esko J D, Leder O, Ornitz D M. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991; 64: 841–848
   PubMed Web of Science ®Google Scholar
• Rapraeger A C, Krufka A, Olwin B B. Requirement of heparin sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 1991; 252: 1705–1708
   PubMed Web of Science ®Google Scholar
• Spivak-Kroizman T, Lemmon M A, Dikic I, Ladbury S E, Pinchasi D., Hwang J, Jaye M, Grumley G, Schlessinger J, Lax I. Heparin-induced oligomerisation of FGF molecules is responsible for FGF receptor dimerization, activation and cell proliferation. Cell 1994; 71: 1015–1024
   Google Scholar
• Jackson D G, Bell J I, Dickinson R, Timans J, Shields J, Whittle N. Proteoglycan forms on the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol 1995; 128: 673–685
   PubMed Web of Science ®Google Scholar
• Bennett K L, Jackson D G, Simon J C, Tanczos E, Peach R, Modrell B, Stamenkovic I, Plowman G, Aruffo A. CD44 isoforms containing exon v3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 1995; 128: 687–698
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Adams D H, Hubscher S, Hirano H, Siebenlist U, Shaw S. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1beta. Nature 1993; 361: 79–82
   PubMed Web of Science ®Google Scholar
• König H, Moll J, Ponta H, Herrlich P. Trans-acting factors regulate the expression of CD44 splice variants. EMBO J 1996; 15: 4030–4039
   PubMed Web of Science ®Google Scholar
• SenGupta D J, Zhang B, Kraemer B, Pochart P, Fields S, Wickens M. A three-hybrid system to detect RNA-protein interactions in vivo. Proc Natl Acad Sci USA 1996; 93: 8496
   PubMed Web of Science ®Google Scholar
• Screaton G R, Bell M V, Jackson D G, Cornelis F B, Gerth U, Bell J I. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992; 89: 12160–12164
   PubMed Web of Science ®Google Scholar
• Tölg C, Hofmann M, Herrlich P, Ponta H. Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res 1993; 21: 1225–1229
   PubMed Web of Science ®Google Scholar
• König H, Ponta H, Herrlich P. Coupling of signal transduction to alternative pre-mRNA splicing by an inducible splice enhancer. EMBO J 1998, in press
   Google Scholar
• Watakabe A, Tanaka K, Shimura Y. The role of exon sequences in splice site selection. Genes Dev 1993; 7: 407–418
   PubMed Web of Science ®Google Scholar
• Tanaka K, Watakabe A, Shimura Y. Polypurine sequences within a downstream exon function as a splicing enhancer. Mol Cell Biol 1994; 14: 1347–1354
   PubMed Web of Science ®Google Scholar